Lactoferrin and Interleukin-6 Interaction in Amniotic Infection
Lactoferrin (Lf) has been found in most biological fluids including amniotic fluid and cervical mucoids in pregnant women, and released from neutrophils in response to the inflammation. As Lf possesses antimicrobial properties, it is widely considered to be an important component of the host defence against microbial infections. It is known that premature labor is caused by amniotic infection with the increase of prostaglandin production. High concentration of the inflammatory cytokines: interleukin-1 β (IL-1 β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) in the amniotic fluid has been known. However, changes of Lf in amniotic fluid with infection has not been reported. In the present study, Lf concentrations in amniotic fluid were measured under the intra-uterine infections state and the biological significance of Lf was investigated. The effects of Lf on the IL-6 and IL-6mRNA production in cultured amnion cells were also investigated. The concentrations of Lf and IL-6 in amniotic fluid with CAM were 8.76±0.65 μg/ml and 6.92±4.88 ng/ml (n=28) respectively and both were significantly higher (p<0.01) than those without CAM [0.86±0.81 μg/ml and 0.34±0.25 ng/ml (n=31)]. Significant positive correlation (r=0.91, p<0.01) between Lf and IL-6 levels in amniotic fluid was found. IL-6 production induced by lipopolysaccharide (LPS) (100ng/m1) in cultured amnion cells was significantly inhibited (p<0.05) under the physiological concentration of Lf in amnion. Total RNA was extracted from the amniotic cells by guianizine solution. RT-PCR procedure and product analysis were performed from one µg aliquote of total RNA. β-actin was used as an international standard and c-DNA samples were followed by 30 cycles of PCR. RTPCR product of IL-6 mRNA was detected by Southern hybridization. Expression of IL6mRNA was inhibited by the addition of Lf. From the results, the possibility that Lf might suppress amniotic IL-6 production under the condition of amniotic infection is suggested. It is also suggested that Lf might act as self defence mechanism from intra-uterine infection.
KeywordsAmniotic Fluid Amniotic Membrane Fetal Membrane Human Lactoferrin Amniotic Fluid Sample
Unable to display preview. Download preview PDF.
- 7.Lonnerdal B (1990) Iron in human milk and cow’s milk–Effects of binding ligands on bioavailability. In: Iron Metabolism in Infants, Lonnerdal B (Ed) CRC Press, Boca Rato, FL, pp 87–107.Google Scholar
- 13.Blanc WA (1981) Pathology of the placenta, membranes, and umbilical cord in bacterial, fungal and viral infections in man. In: Perinatal Diseases International Academy of Pathology Monograph, Vol 22, Blanc WA Ed, Williams & Wilkins, Baltimore, pp 67–132.Google Scholar
- 15.Katsufumi O, Aki Y, Kazuhiro H, Yukiko S, Hiroshi S, Takumi Y (1997) Salivary lactoferrin in neonates with chorioamnionitis. The Showa Univ J Med Sci, 9–1, unpublishedGoogle Scholar
- 16.Chimura T. Hirayama T, Takase M (1993) Lactoferrin in cervical mucus of patients with chorioamnionitis. Jpn Antibiot, 46, 318–322.Google Scholar